Free Research Report as DowDuPont’s Quarterly Sales Jumped 5% and Adjusted EPS Climbed 7%

Stock Monitor: OCI Partners Post Earnings Reporting

LONDON, UK / ACCESSWIRE / June 5, 2018 / If you want access to our free earnings report on DowDuPont Inc. (NYSE: DWDP), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=DWDP. The Company reported its first quarter fiscal 2018 operating and financial results on May 03, 2018. The chemical Company beat revenue and earnings expectations. Additionally, the Company announced that it has achieved cost synergy savings of more than $300 million, which were ahead of its run-rate plan. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for OCI Partners LP (NYSE: OCIP), which also belongs to the Basic Materials sector as the Company DowDuPont. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=OCIP

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, DowDuPont most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=DWDP

Earnings Highlights and Summary

For the first quarter of the fiscal year 2018, DowDuPont’s net sales increased 5% to $21.5 billion, with growth in most operating segments and geographic regions, from pro-forma net sales of $20.5 billion in Q1 2017. The Company’s net sales for the reported quarter included a 4% benefit from currency, primarily from the Euro. DowDuPont’s revenue numbers surpassed analysts’ estimates of $21.36 billion.

For Q1 2018, DowDuPont’s GAAP earnings from continuing operations was $1.10 billion, or $0.47 per diluted share, compared to $888 million, or $0.72 per diluted share, in Q1 2017.

DowDuPont’s adjusted diluted earnings per share (EPS) increased 7% to $1.12 in Q1 2018 compared to $1.05 in Q1 2017. The Company’s adjusted EPS for the reported quarter excluded significant items, totaling net charges of $0.54, as well as a charge for amortization of intangible assets of $0.11 per share. DowDuPont’s earnings exceeded Wall Street’s estimates of $1.10 per share.

DowDuPont’s operating earnings before interest, tax, depreciation, and amortization (EBITDA) rose 6% to $4.9 billion on a pro-forma basis in Q1 2018 from the year ago same period.

During Q1 2018, DowDuPont achieved cost synergy savings of more than $300 million, which were ahead of its run-rate plan and now on pace to deliver a 75% run-rate against its $3.3 billion cost synergy commitment by the end of Q3 2018.

Segment Results

During Q1 2018, DowDuPont’s Materials Science segment’s net sales jumped 17% to $12.0 billion on a y-o-y basis, with double-digit gains in all segments and gains in all regions. The segment’s volume grew 8%; local price rose 5%; and currency improved 4% versus the year ago comparable period. The Materials Science segment’s operating EBITDA surged 23% to $2.6 billion.

Within the Materials Science segment, Performance Materials and Coatings division reported net sales of $2.3 billion, up 12% compared to pro-forma net sales of $2.1 billion in Q1 2017. The unit’s sales rose in all regions, with double-digit increases in Asia/Pacific and Europe, Middle-East, and Africa (EMEA). The unit’s operating EBITDA increased 31% to $628 million from pro-forma operating EBITDA of $481 million in the year ago corresponding period, primarily due to increased pricing, improved product mix and cost, and growth synergies.

DowDuPont’s Specialty Products segment’s net sales advanced 11% to $5.6 billion compared to pro-forma net sales in the year ago same period, with gains in all regions and in most segments. The segment’s volume grew 3%; local price rose 2%; currency improved 4%; and portfolio benefited sales by 2%, compared to Q1 2017. The segment’s operating EBITDA surged 25% to $1.6 billion in Q1 2018.

Within the Specialty Products segment, Nutrition and Biosciences division reported net sales of $1.7 billion in Q1 2018, representing an increase of 21% from pro-forma net sales of $1.4 billion in Q1 2017. The increase was primarily due to a 12% net benefit from portfolio; a 4% benefit from volume; and a 4% benefit from currency. The unit’s operating EBITDA were $418 million in the reported quarter, up 32% from pro-forma operating EBITDA of $317 million in the year ago comparable period, driven by a portfolio benefit, volume growth, cost synergies, and lower pension/OPEB costs.

During Q1 2018, DowDuPont’s Agriculture segment’s net sales decreased 25% to $3.8 billion versus pro-forma net sales in the year ago corresponding period, driven by weather-related delays in the Northern Hemisphere and Brazil seasons. The segment’s volume fell 28% on a y-o-y basis, driven by weather-related delays to the start of planting seasons in the Northern Hemisphere and Brazil; lower expected planted area in both North America and Brazil; and lower sales in the Brazil’s safrinha season, due to a shift to lower-technology corn driven by the delayed summer season harvest. For Q1 2018, the segment’s operating EBITDA declined 39% to $891 million from $1.5 billion in Q1 2017.

Cash Matters

DowDuPont returned nearly $2 billion to shareholders in Q1 2018, through dividends of approximately $0.9 billion and share repurchases of approximately $1 billion.

Stock Performance Snapshot

June 04, 2018 – At Monday’s closing bell, DowDuPont’s stock rose 1.45%, ending the trading session at $67.13.

Volume traded for the day: 9.33 million shares, which was above the 3-month average volume of 8.93 million shares.

Stock performance in the last month – up 5.77%

After yesterday’s close, DowDuPont’s market cap was at $155.54 billion.

Price to Earnings (P/E) ratio was at 122.63.

The stock has a dividend yield of 2.26%.

The stock is part of the Basic Materials sector, categorized under the Chemicals – Major Diversified industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501740